Hatziagelaki E - Search Results

1

The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.

Hatziagelaki E, Jaeger C, Petzoldt R, Seissler J, Scherbaum WA, Federlin K, Bretzel RG. Hatziagelaki E, et al. Horm Metab Res. 1999 Oct;31(10):564-9. doi: 10.1055/s-2007-978796. Horm Metab Res. 1999. PMID: 10596966

2

GAD 65 antibody but not ICA positivity in adult-onset diabetic patients is associated with early progression to clinical insulin dependency.

Hatziagelaki E, Jaeger C, Maeser E, Bretzel RG, Federlin K. Hatziagelaki E, et al. Acta Diabetol. 1996 Dec;33(4):291-4. doi: 10.1007/BF00571567. Acta Diabetol. 1996. PMID: 9033970

3

Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.

Jaeger C, Allendörfer J, Hatziagelaki E, Dyrberg T, Bergis KH, Federlin K, Bretzel RG. Jaeger C, et al. Among authors: hatziagelaki e. Horm Metab Res. 1997 Oct;29(10):510-5. doi: 10.1055/s-2007-979091. Horm Metab Res. 1997. PMID: 9405979

4

Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression.

Jaeger C, Hering BJ, Hatziagelaki E, Federlin K, Bretzel RG. Jaeger C, et al. Among authors: hatziagelaki e. J Mol Med (Berl). 1999 Jan;77(1):45-8. doi: 10.1007/s001090050299. J Mol Med (Berl). 1999. PMID: 9930926

5

The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.

Jaeger C, Hatziagelaki E, Stroedter A, Becker F, Scherer S, Petzoldt R, Federlin K, Bretzel RG. Jaeger C, et al. Among authors: hatziagelaki e. Exp Clin Endocrinol Diabetes. 1999;107(8):496-505. doi: 10.1055/s-0029-1232558. Exp Clin Endocrinol Diabetes. 1999. PMID: 10612480

6

Comparative analysis of organ-specific autoantibodies and celiac disease--associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects.

Jaeger C, Hatziagelaki E, Petzoldt R, Bretzel RG. Jaeger C, et al. Among authors: hatziagelaki e. Diabetes Care. 2001 Jan;24(1):27-32. doi: 10.2337/diacare.24.1.27. Diabetes Care. 2001. PMID: 11194235

7

Modern concepts for the prediction of type 1 diabetes.

Seissler J, Hatziagelaki E, Scherbaum WA. Seissler J, et al. Among authors: hatziagelaki e. Exp Clin Endocrinol Diabetes. 2001;109 Suppl 2:S304-16. doi: 10.1055/s-2001-18590. Exp Clin Endocrinol Diabetes. 2001. PMID: 11460579 Review.

8

Islet transplantation: present clinical situation and future aspects.

Bretzel RG, Brendel M, Eckhard M, Brandhorst D, Jaeger C, Hatziagelaki E, Federlin K. Bretzel RG, et al. Among authors: hatziagelaki e. Exp Clin Endocrinol Diabetes. 2001;109 Suppl 2:S384-99. doi: 10.1055/s-2001-18597. Exp Clin Endocrinol Diabetes. 2001. PMID: 11460586 Review.

9

The role of adiponectin as a compensatory mediator for the primary secretory defect in latent autoimmune diabetes in adults.

Hatziagelaki E, Lambadiari V, Tsiavou A, Gogas H, Bretzel RG, Dimitriadis G. Hatziagelaki E, et al. Clin Ther. 2013 Jul;35(7):1016-24. doi: 10.1016/j.clinthera.2013.06.001. Clin Ther. 2013. PMID: 23870609

10

Predictors of impaired glucose regulation in patients with non-alcoholic fatty liver disease.

Hatziagelaki E, Karageorgopoulos DE, Chounta A, Tsiavou A, Falagas ME, Dimitriadis G. Hatziagelaki E, et al. Exp Diabetes Res. 2012;2012:351974. doi: 10.1155/2012/351974. Epub 2011 Sep 21. Exp Diabetes Res. 2012. PMID: 21960993 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters